Exact Mass: 521.269
Exact Mass Matches: 521.269
Found 262 metabolites which its exact mass value is equals to given mass value 521.269
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Morphiceptin
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides Morphiceptin is a peptide isolated from beta-casein. [HMDB] D018377 - Neurotransmitter Agents > D004723 - Endorphins Morphiceptin is a peptide isolated from beta-casein. Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for enkephalin (?) receptors[1]. Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for enkephalin (?) receptors[1].
LysoPS(18:2(9Z,12Z)/0:0)
LysoPS(18:2(9Z,12Z)/0:0) is a lysophosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylserines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPS(18:2(9Z,12Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position.
Batrachotoxinin A 20-alpha-benzoate
D009676 - Noxae > D011042 - Poisons > D014688 - Venoms
Thienorphine
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
3alpha-[4-(beta-D-glucopyranosyloxy)-3-methoxy-5-(3-methyl-2-butenyl)benzoyloxy]tropane|merresectine D beta-D-glucoside
Ala Glu Phe Arg
Ala Glu Arg Phe
Ala Phe Glu Arg
Ala Phe Arg Glu
Ala Phe Val Trp
Ala Phe Trp Val
Ala Arg Glu Phe
Ala Arg Phe Glu
Ala Val Phe Trp
Ala Val Trp Phe
Ala Trp Phe Val
Ala Trp Val Phe
Glu Ala Phe Arg
Glu Ala Arg Phe
Glu Phe Ala Arg
Glu Phe Arg Ala
Glu Arg Ala Phe
Glu Arg Phe Ala
Phe Ala Glu Arg
Phe Ala Arg Glu
Phe Ala Val Trp
Phe Ala Trp Val
Phe Glu Ala Arg
Phe Glu Arg Ala
Phe Gly Ile Trp
Phe Gly Leu Trp
Phe Gly Trp Ile
Phe Gly Trp Leu
Phe Ile Gly Trp
Phe Ile Trp Gly
Phe Lys Met Pro
Phe Lys Asn Asn
Phe Lys Pro Met
Phe Leu Gly Trp
Phe Leu Trp Gly
Phe Met Lys Pro
Phe Met Pro Lys
Phe Asn Lys Asn
Phe Asn Asn Lys
Phe Pro Lys Met
Phe Pro Met Lys
Phe Arg Ala Glu
Phe Arg Glu Ala
Phe Val Ala Trp
Phe Val Trp Ala
Phe Trp Ala Val
Phe Trp Gly Ile
Phe Trp Gly Leu
Phe Trp Ile Gly
Phe Trp Leu Gly
Phe Trp Val Ala
Gly Phe Ile Trp
Gly Phe Leu Trp
Gly Phe Trp Ile
Gly Phe Trp Leu
Gly Ile Phe Trp
Gly Ile Trp Phe
Gly Leu Phe Trp
Gly Leu Trp Phe
Gly Trp Phe Ile
Gly Trp Phe Leu
Gly Trp Ile Phe
Gly Trp Leu Phe
His His Lys Thr
His His Thr Lys
His Lys His Thr
His Lys Thr His
His Thr His Lys
His Thr Lys His
Ile Phe Gly Trp
Ile Phe Trp Gly
Ile Gly Phe Trp
Ile Gly Trp Phe
Ile Lys Met Met
Ile Met Lys Met
Ile Met Met Lys
Ile Trp Phe Gly
Ile Trp Gly Phe
Lys Phe Met Pro
Lys Phe Asn Asn
Lys Phe Pro Met
Lys His His Thr
Lys His Thr His
Lys Ile Met Met
Lys Leu Met Met
Lys Met Phe Pro
Lys Met Ile Met
Lys Met Leu Met
Lys Met Met Ile
Lys Met Met Leu
Lys Met Pro Phe
Lys Asn Phe Asn
Lys Asn Asn Phe
Lys Pro Phe Met
Lys Pro Met Phe
Lys Thr His His
Leu Phe Gly Trp
Leu Phe Trp Gly
Leu Gly Phe Trp
Leu Gly Trp Phe
Leu Lys Met Met
Leu Met Lys Met
Leu Met Met Lys
Leu Trp Phe Gly
Leu Trp Gly Phe
Met Phe Lys Pro
Met Phe Pro Lys
Met Ile Lys Met
Met Ile Met Lys
Met Lys Phe Pro
Met Lys Ile Met
Met Lys Leu Met
Met Lys Met Ile
Met Lys Met Leu
Met Lys Pro Phe
Met Leu Lys Met
Met Leu Met Lys
Met Met Ile Lys
Met Met Lys Ile
Met Met Lys Leu
Met Met Leu Lys
Met Pro Phe Lys
Met Pro Lys Phe
Asn Phe Lys Asn
Asn Phe Asn Lys
Asn Lys Phe Asn
Asn Lys Asn Phe
Asn Asn Phe Lys
Asn Asn Lys Phe
Pro Phe Lys Met
Pro Phe Met Lys
Pro Lys Phe Met
Pro Lys Met Phe
Pro Met Phe Lys
Pro Met Lys Phe
Pro Arg Ser Tyr
Pro Arg Tyr Ser
Pro Ser Arg Tyr
Pro Ser Tyr Arg
Pro Tyr Arg Ser
Pro Tyr Ser Arg
Arg Ala Glu Phe
Arg Ala Phe Glu
Arg Glu Ala Phe
Arg Glu Phe Ala
Arg Phe Ala Glu
Arg Phe Glu Ala
Arg Pro Ser Tyr
Arg Pro Tyr Ser
Arg Ser Pro Tyr
Arg Ser Tyr Pro
Arg Tyr Pro Ser
Arg Tyr Ser Pro
Ser Pro Arg Tyr
Ser Pro Tyr Arg
Ser Arg Pro Tyr
Ser Arg Tyr Pro
Ser Tyr Pro Arg
Ser Tyr Arg Pro
Thr His His Lys
Thr His Lys His
Thr Lys His His
Val Ala Phe Trp
Val Ala Trp Phe
Val Phe Ala Trp
Val Phe Trp Ala
Val Trp Ala Phe
Val Trp Phe Ala
Trp Ala Phe Val
Trp Ala Val Phe
Trp Phe Ala Val
Trp Phe Gly Ile
Trp Phe Gly Leu
Trp Phe Ile Gly
Trp Phe Leu Gly
Trp Phe Val Ala
Trp Gly Phe Ile
Trp Gly Phe Leu
Trp Gly Ile Phe
Trp Gly Leu Phe
Trp Ile Phe Gly
Trp Ile Gly Phe
Trp Leu Phe Gly
Trp Leu Gly Phe
Trp Val Ala Phe
Trp Val Phe Ala
Tyr Pro Arg Ser
Tyr Pro Ser Arg
Tyr Arg Pro Ser
Tyr Arg Ser Pro
Tyr Ser Pro Arg
Tyr Ser Arg Pro
Deproceptin
Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for enkephalin (?) receptors[1]. Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for enkephalin (?) receptors[1].
Tauroursodeoxycholic acid sodium salt
Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.
Sodium taurochenodeoxycholate
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Taurochenodeoxycholic acid (12-Deoxycholyltaurine) sodium is one of the main bioactive substances of animals' bile acid. Taurochenodeoxycholic acid sodium induces apoptosis and shows obvious anti-inflammatory and immune regulation properties[1][2].
Sodium Taurodeoxycholate
Taurodeoxycholate sodium salt is a bile salt-related anionic detergent used for isolation of membrane proteins including inner mitochondrial membrane proteins. Taurodeoxycholate (TDCA) inhibits various inflammatory responses[1] [2][3].
8-[1-(1,3-Benzodioxol-5-yl)-3-(1-piperidinyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one
N-[[(2S,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
[(1R)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-(4-oxanyl)methanone
[(1S)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-(4-oxanyl)methanone
N-[[(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[(2R,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-pyrazinecarboxamide
N-[(2S,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-pyrazinecarboxamide
N-[(2S,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]pyrazine-2-carboxamide
N-[[(2R,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(2R,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(2S,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(2S,3R)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[[(2R,3S)-8-[2-(2-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
N-[(2S,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-pyrazinecarboxamide
N-[(2S,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]pyrazine-2-carboxamide
N-[(2R,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-2-pyrazinecarboxamide
2-amino-3-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxypropanoic acid
Morphiceptin
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004723 - Endorphins Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for enkephalin (?) receptors[1]. Morphiceptin is a potent and specific agonist for morphine (μ) receptors. Morphiceptin, as a synthetic peptide, is the amide of a fragment of the milk protein β-casein. Morphiceptin has morphinelike activities and is highly specific for morphine (μ) receptors but not for enkephalin (?) receptors[1].
1-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoserine
Exarafenib
Exarafenib (RAF/KIN_2787) is an orally-available, selective pan-RAF inhibitor. Exarafenib is effective in RAF-dependent cancers, including all classes of BRAF alterations. Exarafenib suppresses MAPK signaling in RAF-dependent melanoma cell lines. Exarafenib has anticancer activity[1][2].